Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma

被引:8
作者
Hung, Ya-Wen [1 ,2 ]
Lee, I-Cheng [1 ,3 ]
Chi, Chen-Ta [1 ,3 ,4 ]
Lee, Rheun-Chuan [5 ]
Liu, Chien-An [5 ]
Chiu, Nai-Chi [5 ]
Hwang, Hsuen-En [5 ]
Chao, Yee [6 ]
Hou, Ming-Chih [1 ,3 ]
Huang, Yi-Hsiang [1 ,3 ,4 ,7 ,8 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Hlth Examinat Ctr, Taoyuan Branch, Taoyuan, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Sch Med, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan
[6] Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan
[7] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taiwan201 Shih Pai Rd,Sec 2, Taipei 112, Taiwan
关键词
CLINICAL-PRACTICE GUIDELINES; ART SCORE; RETREATMENT; MANAGEMENT; PATHOLOGY; PROPOSAL; JAPAN;
D O I
10.1159/000530950
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionOutcomes of transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC) are diverse because of the heterogeneity of tumor burden. Radiologic pattern is one criterion for determining whether TACE is unsuitable. However, additional evidences are required. This study determined the influence of radiologic morphology on the outcomes of initial and subsequent TACE. MethodsFrom January 2007 to September 2021, 633 treatment-naive patients with HCC with intermediate-stage HCC undergoing TACE were retrospectively enrolled. Of these patients, 386 patients received repeated TACE. The radiological features of HCC were evaluated by two radiologists and classified into encapsulated nodular type, simple nodular type with extranodular growth, confluent multinodular type, and infiltrative type. The objective response rate (ORR) and survival rate after initial and subsequent TACE among various radiologic morphologies were compared.ResultsAfter initial TACE, encapsulated nodular type HCC had the highest ORR (58%), followed by extranodular type (45.8%), confluent multinodular type (29%), and infiltrative type (19.5%). Notably, radiologic pattern was highly associated with tumor burden. Tumor burden and radiologic morphology was significantly associated with ORR and overall survival (OS) in the multivariate analysis. In 386 patients with subsequent TACE, encapsulated nodular type HCC had the highest ORR (48.7%), followed by extranodular type (37.3%), confluent multinodular type (26.2%), and infiltrative type (10%). In the multivariate analysis, radiologic features were significant independent predictors of ORR and OS after receiving subsequent TACE. ConclusionRadiologic patterns determine the outcomes of initial and subsequent TACE. Systemic therapy should be considered for patients with intermediate-stage HCC with unfavorable radiologic patterns.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 37 条
[1]   Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process [J].
Adhoute, Xavier ;
Penaranda, Guillaume ;
Naude, Sebastien ;
Raoul, Jean Luc ;
Perrier, Herve ;
Bayle, Olivier ;
Monnet, Olivier ;
Beaurain, Patrick ;
Bazin, Christophe ;
Pol, Bernard ;
Le Folgoc, Gaelle ;
Castellani, Paul ;
Bronowicki, Jean Pierre ;
Bourliere, Marc .
JOURNAL OF HEPATOLOGY, 2015, 62 (04) :855-862
[2]   Global Burden of 5 Major Types of Gastrointestinal Cancer [J].
Arnold, Melina ;
Abnet, Christian C. ;
Neale, Rachel E. ;
Vignat, Jerome ;
Giovannucci, Edward L. ;
McGlynn, Katherine A. ;
Bray, Freddie .
GASTROENTEROLOGY, 2020, 159 (01) :335-+
[3]   Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection [J].
Chi, Chen-Ta ;
Lee, I-Cheng ;
Lee, Rheun-Chuan ;
Hung, Ya-Wen ;
Su, Chien-Wei ;
Hou, Ming-Chih ;
Chao, Yee ;
Huang, Yi-Hsiang .
CANCERS, 2021, 13 (17)
[4]   EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018) [J].
Galle, Peter R. ;
Forner, Alejandro ;
Llovet, Josep M. ;
Mazzaferro, Vincenzo ;
Piscaglia, Fabio ;
Raoul, Jean-Luc ;
Schirmacher, Peter ;
Vilgrain, Valerie .
JOURNAL OF HEPATOLOGY, 2019, 70 (04) :817-817
[5]   Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach [J].
Han, Guohong ;
Berhane, Sarah ;
Toyoda, Hidenori ;
Bettinger, Dominik ;
Elshaarawy, Omar ;
Chan, Anthony W. H. ;
Kirstein, Martha ;
Mosconi, Cristina ;
Hucke, Florian ;
Palmer, Derrica ;
Pinato, David J. ;
Sharma, Rohini ;
Ottaviani, Diego ;
Jang, Jeong W. ;
Labeur, Tim A. ;
van Delden, Otto M. ;
Pirisi, Mario ;
Stern, Nick ;
Sangro, Bruno ;
Meyer, Tim ;
Fateen, Waleed ;
Garcia-Finana, Marta ;
Gomaa, Asmaa ;
Waked, Imam ;
Rewisha, Eman ;
Aithal, Guru P. ;
Travis, Simon ;
Kudo, Masatoshi ;
Cucchetti, Alessandro ;
Peck-Radosavljevic, Markus ;
Takkenberg, R. B. ;
Chan, Stephen L. ;
Vogel, Arndt ;
Johnson, Philip J. .
HEPATOLOGY, 2020, 72 (01) :198-212
[6]   HEPATOCELLULAR-CARCINOMA - EFFICACY OF TRANSCATHETER OILY CHEMOEMBOLIZATION IN RELATION TO MACROSCOPIC AND MICROSCOPIC PATTERNS OF TUMOR-GROWTH AMONG 100 PATIENTS WITH PARTIAL-HEPATECTOMY [J].
HASHIMOTO, T ;
NAKAMURA, H ;
HORI, S ;
TOMODA, K ;
NAKANISHI, K ;
MURAKAMI, T ;
KOZUKA, T ;
MONDEN, M ;
GOTOH, M ;
KURODA, C ;
WAKASA, K ;
SAKURAI, M .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 18 (02) :82-86
[7]   Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system [J].
Hsu, Chia-Yang ;
Lee, Yun-Hsuan ;
Hsia, Cheng-Yuan ;
Huang, Yi-Hsiang ;
Su, Chien-Wei ;
Lin, Han-Chieh ;
Lee, Rheun-Chuan ;
Chiou, Yi-You ;
Lee, Fa-Yauh ;
Huo, Teh-Ia .
HEPATOLOGY, 2013, 57 (01) :112-119
[8]   How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma [J].
Hucke, Florian ;
Pinter, Matthias ;
Graziadei, Ivo ;
Bota, Simona ;
Vogel, Wolfgang ;
Mueller, Christian ;
Heinzl, Harald ;
Waneck, Fredrik ;
Trauner, Michael ;
Peck-Radosavljevic, Markus ;
Sieghart, Wolfgang .
JOURNAL OF HEPATOLOGY, 2014, 61 (06) :1287-1296
[9]   The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE [J].
Hucke, Florian ;
Sieghart, Wolfgang ;
Pinter, Matthias ;
Graziadei, Ivo ;
Vogel, Wolfgang ;
Mueller, Christian ;
Heinzl, Harald ;
Waneck, Fredrik ;
Trauner, Michael ;
Peck-Radosavljevic, Markus .
JOURNAL OF HEPATOLOGY, 2014, 60 (01) :118-126
[10]   Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria [J].
Hung, Ya-Wen ;
Lee, I-Cheng ;
Chi, Chen-Ta ;
Lee, Rheun-Chuan ;
Liu, Chien-An ;
Chiu, Nai-Chi ;
Hwang, Hsuen-En ;
Chao, Yee ;
Hou, Ming-Chih ;
Huang, Yi-Hsiang .
LIVER CANCER, 2021, 10 (06) :629-640